Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial
Roche Holding ROP 1.21%increase; up pointing triangle said a drug candidate showed better potential than existing therapies in…
Roche Shares Fall After Breast-Cancer Treatment Misses Goal in Late-Stage Study
Roche Holding shares fell after the company said a late-stage study for an experimental breast-cancer treatment missed its…
Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion
Novartis NOVN -1.20%decrease; red down pointing triangle said it agreed to buy biotech company Excellergy for up to…
Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion
Novartis NOVN 1.69%increase; green up pointing triangle said it agreed to buy biotech company Excellergy for up to…